Two Sigma Advisers
TTPH

Two Sigma Advisers’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Two Sigma Advisers’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,774
Closed -$30K – 2628
2019
Q4 		$30K Sell
10,774
-2,100
-16% -$6.74K ﹤0.01% 2312
2019
Q3 		$68K Sell
12,874
-641
-5% -$4.27K ﹤0.01% 2138
2019
Q2 		$130K Sell
13,515
-60
-0.4% -$1.1K ﹤0.01% 2188
2019
Q1 		$364K Buy
13,575
+2,525
+23% +$64.3K ﹤0.01% 1921
2018
Q4 		$250K Buy
11,050
+3,695
+50% +$144K ﹤0.01% 2051
2018
Q3 		$406K Buy
+7,355
New +$470K ﹤0.01% 1871
2017
Q4 		– Sell
-920
Closed -$126K – 2436
2017
Q3 		$126K Sell
920
-455
-33% -$60.9K ﹤0.01% 2104
2017
Q2 		$196K Sell
1,375
-2,055
-60% -$318K ﹤0.01% 2125
2017
Q1 		$630K Buy
3,430
+1,000
+41% +$112K ﹤0.01% 1795
2016
Q4 		$196K Sell
2,430
-155
-6% -$12.3K ﹤0.01% 2195
2016
Q3 		$198K Sell
2,585
-2,065
-44% -$165K ﹤0.01% 2046
2016
Q2 		$400K Sell
4,650
-475
-9% -$43.5K ﹤0.01% 1607
2016
Q1 		$475K Buy
5,125
+1,400
+38% +$140K ﹤0.01% 1481
2015
Q4 		$747K Sell
3,725
-545
-13% -$109K ﹤0.01% 1159
2015
Q3 		$637K Buy
4,270
+3,940
+1,194% +$2.89M ﹤0.01% 1194
2015
Q2 		$313K Buy
+330
New +$270K ﹤0.01% 1600

Other funds holding TTPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's TTPH Position: Q1 2020 in Review

Two Sigma Advisers sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2020, closing a stake of 10,774 shares — an estimated $30K sold.

Two Sigma Advisers first reported a position in TTPH in Q2 2015 and held it in 16 quarters. The position peaked at $747K in Q4 2015. 25 funds tracked by Wall St. Rank hold TTPH as of Q1 2020.

  • Two Sigma Advisers reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 10,774 Tetraphase Pharmaceuticals, Inc. shares in Q1 2020, an estimated $30K.
  • Two Sigma Advisers first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
  • Two Sigma Advisers's Tetraphase Pharmaceuticals, Inc. position peaked at $747K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2020.

Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.